Ben Yong
SEC insider (Form 3/4/5 filer). CIK 0001967669. Chief Med & Dev Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Ben Yong has filed insider reports for
- BridgeBio Oncology Therapeutics, Inc. (BBOT): Officer, Chief Med & Dev Officer
- Corbus Pharmaceuticals Holdings, Inc. (CRBP): Director
Ben Yong
CIK: 0001967669
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 1, 2026BBOT
BridgeBio Oncology Therapeutics, Inc.
Tax PaymentDirect1K shares at avg. $3.94$4K - Sep 14, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
SaleDirect2K shares at avg. $7.84$16K - Jul 1, 2026BBOT
BridgeBio Oncology Therapeutics, Inc.
Tax PaymentDirect1K shares at avg. $7.80$8K - May 19, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
AwardDirect3.8K shares- - Apr 1, 2026BBOT
BridgeBio Oncology Therapeutics, Inc.
Tax PaymentDirect1K shares at avg. $9.03$9K - Mar 10, 2026BBOT
BridgeBio Oncology Therapeutics, Inc.
AwardDirect46.7K shares- - Aug 26, 2025BBOT
BridgeBio Oncology Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
357.2K shares- - May 30, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
AwardDirect4.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  BBOT BridgeBio Oncology Therapeutics, Inc. | Tax Payment | 1,047 | $3.94 | $4,125 | Direct |
| Sep 14, 2026 |  CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 2,000 | $7.84 | $15,683 | Direct |
| Jul 1, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc. | Tax Payment | 1,047 | $7.80 | $8,167 | Direct |
| May 19, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Award | 3,800 | - | $0 | Direct |
| Apr 1, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc. | Tax Payment | 1,047 | $9.03 | $9,454 | Direct |
| Mar 10, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc. | Award | 46,670 | - | $0 | Direct |
| Aug 26, 2025 | BBOT BridgeBio Oncology Therapeutics, Inc. | Award Stock Option (Right to Buy) | 357,177 | - | - | Direct |
| May 30, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Award | 4,800 | - | - | Direct |
1-8 of 8 transactions